Vantive Health LLC

Quick facts

Marketed products

• Dianeal · Other
• Extraneal · Other
• Nutrineal · Other

Phase 3 pipeline

• Dianeal, Extraneal, Nutrineal · Nephrology / Renal replacement therapy
  These are peritoneal dialysis solutions that facilitate fluid and solute exchange across the peritoneal membrane to remove waste products and excess water from the blood in patients with kidney failure.
• Experimental Peritoneal Dialysis Solution · Nephrology
  An experimental peritoneal dialysis solution designed to improve solute clearance and fluid removal in patients with end-stage renal disease undergoing peritoneal dialysis.
• Prismocitrate 18 · Nephrology / Critical Care
  Prismocitrate 18 is a citrate-based anticoagulant used in regional citrate anticoagulation (RCA) for extracorporeal therapies.

Phase 2 pipeline

• Biphozyl · Other
• Prismasol 2
• Regiocit · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Vantive Health LLC portfolio CI brief
• Vantive Health LLC pipeline updates RSS